Chronic myeloid leukemia following treatment for bilateral retinoblastoma

Saved in:

Bibliographic Details
Published in	Pediatric blood & cancer Vol. 65; no. 9; pp. e27107 - n/a
Main Authors	Kamitori, Tatsuya, Umeda, Katsutsugu, Tasaka, Keiji, Ogata, Hideto, Mikami, Takashi, Kato, Itaru, Hiramatsu, Hidefumi, Kondo, Tadakazu, Adachi, Souichi
Format	Journal Article
Language	English
Published	United States Wiley Subscription Services, Inc 01.09.2018
Subjects	Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Brachytherapy - adverse effects Chronic myeloid leukemia Combined Modality Therapy Cryotherapy Dasatinib - therapeutic use Eye Enucleation Hematology Humans Infant Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - etiology Light Coagulation Male Melphalan - therapeutic use Myeloid leukemia Neoplasms, Multiple Primary - therapy Neoplasms, Radiation-Induced - drug therapy Neoplasms, Radiation-Induced - etiology Neoplasms, Second Primary - drug therapy Neoplasms, Second Primary - etiology Oncology Pediatrics Radiotherapy, Adjuvant - adverse effects Remission Induction Retinoblastoma Retinoblastoma - therapy
Online Access	Get full text
ISSN	1545-5009 1545-5017 1545-5017
DOI	10.1002/pbc.27107

More Information
Bibliography:	SourceType-Scholarly Journals-1 ObjectType-Correspondence-2 content type line 14 ObjectType-Letter to the Editor-1 ObjectType-Case Study-2 ObjectType-Correspondence-3 content type line 23 ObjectType-Report-1
ISSN:	1545-5009 1545-5017 1545-5017
DOI:	10.1002/pbc.27107